Evidence map›Paper›PMID 31253643›Full record

ArticleNeurology2019

Building a neuroinfectious disease consensus curriculum.

Arun Venkatesan, Felicia C Chow, Allen Aksamit, Russell Bartt, Thomas P Bleck, Cheryl Jay, Daniel M Pastula, Karen L Roos, Jeffrey Rumbaugh, Deanna Saylor and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Arun VenkatesanFrom the Neuro-Infectious Diseases Section (A.V., F.C.C., A.A., R.B., T.P.B., C.J., D.M.P., K.L.R., J.R., D.S., T.A.C.), American Academy of Neurology, Minneapolis, MN; Johns Hopkins University (A.V., D.S.), Baltimore, MD; University of California (F.C.C., C.J.), San Francisco; Mayo Clinic (A.A.), Rochester, MN; Blue Sky Neurology (R.B.), Englewood, CO; Rush Medical College (T.P.B.), Chicago; University of Colorado and Colorado School of Public Health (D.M.P.), Aurora; Indiana University (K.R.), Indianapolis; Remyelix Neurology & Multiple Sclerosis Institute (J.R.), Tampa, FL; University of Iowa (T.A.C.), Iowa City.
Felicia C ChowFrom the Neuro-Infectious Diseases Section (A.V., F.C.C., A.A., R.B., T.P.B., C.J., D.M.P., K.L.R., J.R., D.S., T.A.C.), American Academy of Neurology, Minneapolis, MN; Johns Hopkins University (A.V., D.S.), Baltimore, MD; University of California (F.C.C., C.J.), San Francisco; Mayo Clinic (A.A.), Rochester, MN; Blue Sky Neurology (R.B.), Englewood, CO; Rush Medical College (T.P.B.), Chicago; University of Colorado and Colorado School of Public Health (D.M.P.), Aurora; Indiana University (K.R.), Indianapolis; Remyelix Neurology & Multiple Sclerosis Institute (J.R.), Tampa, FL; University of Iowa (T.A.C.), Iowa City.
Allen AksamitFrom the Neuro-Infectious Diseases Section (A.V., F.C.C., A.A., R.B., T.P.B., C.J., D.M.P., K.L.R., J.R., D.S., T.A.C.), American Academy of Neurology, Minneapolis, MN; Johns Hopkins University (A.V., D.S.), Baltimore, MD; University of California (F.C.C., C.J.), San Francisco; Mayo Clinic (A.A.), Rochester, MN; Blue Sky Neurology (R.B.), Englewood, CO; Rush Medical College (T.P.B.), Chicago; University of Colorado and Colorado School of Public Health (D.M.P.), Aurora; Indiana University (K.R.), Indianapolis; Remyelix Neurology & Multiple Sclerosis Institute (J.R.), Tampa, FL; University of Iowa (T.A.C.), Iowa City.
Russell BarttFrom the Neuro-Infectious Diseases Section (A.V., F.C.C., A.A., R.B., T.P.B., C.J., D.M.P., K.L.R., J.R., D.S., T.A.C.), American Academy of Neurology, Minneapolis, MN; Johns Hopkins University (A.V., D.S.), Baltimore, MD; University of California (F.C.C., C.J.), San Francisco; Mayo Clinic (A.A.), Rochester, MN; Blue Sky Neurology (R.B.), Englewood, CO; Rush Medical College (T.P.B.), Chicago; University of Colorado and Colorado School of Public Health (D.M.P.), Aurora; Indiana University (K.R.), Indianapolis; Remyelix Neurology & Multiple Sclerosis Institute (J.R.), Tampa, FL; University of Iowa (T.A.C.), Iowa City.
Thomas P BleckFrom the Neuro-Infectious Diseases Section (A.V., F.C.C., A.A., R.B., T.P.B., C.J., D.M.P., K.L.R., J.R., D.S., T.A.C.), American Academy of Neurology, Minneapolis, MN; Johns Hopkins University (A.V., D.S.), Baltimore, MD; University of California (F.C.C., C.J.), San Francisco; Mayo Clinic (A.A.), Rochester, MN; Blue Sky Neurology (R.B.), Englewood, CO; Rush Medical College (T.P.B.), Chicago; University of Colorado and Colorado School of Public Health (D.M.P.), Aurora; Indiana University (K.R.), Indianapolis; Remyelix Neurology & Multiple Sclerosis Institute (J.R.), Tampa, FL; University of Iowa (T.A.C.), Iowa City.
Cheryl JayFrom the Neuro-Infectious Diseases Section (A.V., F.C.C., A.A., R.B., T.P.B., C.J., D.M.P., K.L.R., J.R., D.S., T.A.C.), American Academy of Neurology, Minneapolis, MN; Johns Hopkins University (A.V., D.S.), Baltimore, MD; University of California (F.C.C., C.J.), San Francisco; Mayo Clinic (A.A.), Rochester, MN; Blue Sky Neurology (R.B.), Englewood, CO; Rush Medical College (T.P.B.), Chicago; University of Colorado and Colorado School of Public Health (D.M.P.), Aurora; Indiana University (K.R.), Indianapolis; Remyelix Neurology & Multiple Sclerosis Institute (J.R.), Tampa, FL; University of Iowa (T.A.C.), Iowa City.
Daniel M PastulaFrom the Neuro-Infectious Diseases Section (A.V., F.C.C., A.A., R.B., T.P.B., C.J., D.M.P., K.L.R., J.R., D.S., T.A.C.), American Academy of Neurology, Minneapolis, MN; Johns Hopkins University (A.V., D.S.), Baltimore, MD; University of California (F.C.C., C.J.), San Francisco; Mayo Clinic (A.A.), Rochester, MN; Blue Sky Neurology (R.B.), Englewood, CO; Rush Medical College (T.P.B.), Chicago; University of Colorado and Colorado School of Public Health (D.M.P.), Aurora; Indiana University (K.R.), Indianapolis; Remyelix Neurology & Multiple Sclerosis Institute (J.R.), Tampa, FL; University of Iowa (T.A.C.), Iowa City.
Karen L RoosFrom the Neuro-Infectious Diseases Section (A.V., F.C.C., A.A., R.B., T.P.B., C.J., D.M.P., K.L.R., J.R., D.S., T.A.C.), American Academy of Neurology, Minneapolis, MN; Johns Hopkins University (A.V., D.S.), Baltimore, MD; University of California (F.C.C., C.J.), San Francisco; Mayo Clinic (A.A.), Rochester, MN; Blue Sky Neurology (R.B.), Englewood, CO; Rush Medical College (T.P.B.), Chicago; University of Colorado and Colorado School of Public Health (D.M.P.), Aurora; Indiana University (K.R.), Indianapolis; Remyelix Neurology & Multiple Sclerosis Institute (J.R.), Tampa, FL; University of Iowa (T.A.C.), Iowa City.
Jeffrey RumbaughFrom the Neuro-Infectious Diseases Section (A.V., F.C.C., A.A., R.B., T.P.B., C.J., D.M.P., K.L.R., J.R., D.S., T.A.C.), American Academy of Neurology, Minneapolis, MN; Johns Hopkins University (A.V., D.S.), Baltimore, MD; University of California (F.C.C., C.J.), San Francisco; Mayo Clinic (A.A.), Rochester, MN; Blue Sky Neurology (R.B.), Englewood, CO; Rush Medical College (T.P.B.), Chicago; University of Colorado and Colorado School of Public Health (D.M.P.), Aurora; Indiana University (K.R.), Indianapolis; Remyelix Neurology & Multiple Sclerosis Institute (J.R.), Tampa, FL; University of Iowa (T.A.C.), Iowa City.
Deanna SaylorFrom the Neuro-Infectious Diseases Section (A.V., F.C.C., A.A., R.B., T.P.B., C.J., D.M.P., K.L.R., J.R., D.S., T.A.C.), American Academy of Neurology, Minneapolis, MN; Johns Hopkins University (A.V., D.S.), Baltimore, MD; University of California (F.C.C., C.J.), San Francisco; Mayo Clinic (A.A.), Rochester, MN; Blue Sky Neurology (R.B.), Englewood, CO; Rush Medical College (T.P.B.), Chicago; University of Colorado and Colorado School of Public Health (D.M.P.), Aurora; Indiana University (K.R.), Indianapolis; Remyelix Neurology & Multiple Sclerosis Institute (J.R.), Tampa, FL; University of Iowa (T.A.C.), Iowa City.
Tracey A ChoFrom the Neuro-Infectious Diseases Section (A.V., F.C.C., A.A., R.B., T.P.B., C.J., D.M.P., K.L.R., J.R., D.S., T.A.C.), American Academy of Neurology, Minneapolis, MN; Johns Hopkins University (A.V., D.S.), Baltimore, MD; University of California (F.C.C., C.J.), San Francisco; Mayo Clinic (A.A.), Rochester, MN; Blue Sky Neurology (R.B.), Englewood, CO; Rush Medical College (T.P.B.), Chicago; University of Colorado and Colorado School of Public Health (D.M.P.), Aurora; Indiana University (K.R.), Indianapolis; Remyelix Neurology & Multiple Sclerosis Institute (J.R.), Tampa, FL; University of Iowa (T.A.C.), Iowa City. tracey-cho@uiowa.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo delineate a comprehensive curriculum for fellowship training in neuroinfectious diseases, we conducted a modified Delphi approach to reach consensus among 11 experts in the field.

methodsThe authors invited a diverse range of experts from the American Academy of Neurology Neuro-Infectious Diseases (AAN Neuro-ID) Section to participate in a consensus process using a modified Delphi technique.

resultsA comprehensive list of topics was generated with 101 initial items. Through 3 rounds of voting and discussion, a curriculum with 83 items reached consensus.

conclusionsThe modified Delphi technique provides an efficient and rigorous means to reach consensus on topics requiring expert opinion. The AAN Neuro-ID section provided the pool of diverse experts, the infrastructure, and the community through which to accomplish the consensus project successfully. This process could be applied to other subspecialties and sections at the AAN.

Indexed as

Central Nervous System InfectionsConsensus Statements as TopicCurriculumNeurologyClinical CompetenceDelphi TechniqueHumans

Identifiers

PMID31253643
PMCPMC6693428

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.